{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:06:25Z","timestamp":1779095185026,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["202103AC100002"],"award-info":[{"award-number":["202103AC100002"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011635","name":"Chinese Academy of Medical Sciences Fuwai Hospital","doi-asserted-by":"publisher","award":["2024-GSP-T J-4"],"award-info":[{"award-number":["2024-GSP-T J-4"]}],"id":[{"id":"10.13039\/501100011635","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ahj.2026.107362","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:59:56Z","timestamp":1769615996000},"page":"107362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["STrategies for antithrombotic tRreatment following transcatheter edge-to-edge repair in patients with severe mitral regurgitation: Rationale and design of STAR-TEER trial"],"prefix":"10.1016","volume":"296","author":[{"given":"Chuangshi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zizheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangzhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianrui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouzheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangbin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107362_bib0001","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0140-6736(16)00558-4","article-title":"Mitral valve disease\u2013current management and future challenges","volume":"387","author":"Nishimura","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2026.107362_bib0002","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107362_bib0003","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107362_bib0004","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1056\/NEJMc2416118","article-title":"Transcatheter repair versus mitral-valve surgery for secondary mitral regurgitation","volume":"392","author":"Hsu","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107362_bib0005","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJMc2416116","article-title":"Transcatheter valve repair in heart failure with moderate to severe mitral regurgitation","volume":"392","author":"Mewton","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107362_bib0006","first-page":"e7453","article-title":"The frequency of left atrial thrombus on transthoracic echocardiogram in patients with mitral stenosis","volume":"12","author":"Ahmed","year":"2020","journal-title":"Cureus."},{"key":"10.1016\/j.ahj.2026.107362_bib0007","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12872-025-04473-6","article-title":"Prevalence and predictors of left atrial thrombus in patients with rheumatic atrial fibrillation undergoing cardiac surgery: a cross-sectional study","volume":"25","author":"Cui","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ahj.2026.107362_bib0008","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jcin.2018.12.012","article-title":"The prevalence and impact of atrial fibrillation on 1-year outcomes in patients undergoing transcatheter mitral valve repair: results from the Society of Thoracic Surgeons\/American College of Cardiology transcatheter valve therapy registry","volume":"12","author":"Arora","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107362_bib0009","first-page":"e35","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107362_bib0010","first-page":"524","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for cardio-thoracic surgery (EACTS)","volume":"75","author":"Vahanian","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.ahj.2026.107362_bib0011","article-title":"Antithrombotic treatment and its association with outcome in a multicenter cohort of transcatheter edge-to-edge mitral valve repair patients","volume":"9","author":"Waechter","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.ahj.2026.107362_bib0012","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.jcin.2024.09.035","article-title":"Trends predictors, and outcomes of bleeding complications after mitral transcatheter edge-to-edge repair: TVT registry insights","volume":"17","author":"Singh","year":"2024","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.ahj.2026.107362_bib0013","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/CIRCULATIONAHA.123.066943","article-title":"Stopping aspirin within 1 month after stenting for ticagrelor monotherapy in acute coronary syndrome: the T-PASS randomized noninferiority trial","volume":"149","author":"Hong","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107362_bib0014","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107362_bib0015","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107362_bib0016","first-page":"382","article-title":"Bleeding and thrombotic risk of different antiplatelet regimens posttranscatheter edge-to-edge mitral valve repair in patients with an indication for oral anticoagulation: results from an all-comers national registry","volume":"103","author":"Claeys","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107362_bib0017","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/eurheartj\/ehv333","article-title":"Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the mitral valve academic research consortium","volume":"36","author":"Stone","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107362_bib0018","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2026.107362_bib0019","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jtcvs.2012.09.002","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document","volume":"145","author":"Kappetein","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2026.107362_bib0021","doi-asserted-by":"crossref","first-page":"678","DOI":"10.21037\/cdt.2018.06.08","article-title":"Antiplatelet therapy in valvular and structural heart disease interventions","volume":"8","author":"Nusca","year":"2018","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.ahj.2026.107362_bib0022","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jacc.2013.12.062","article-title":"Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study","volume":"64","author":"Glower","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107362_bib0026","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.amjcard.2017.09.027","article-title":"Bleeding complications after percutaneous mitral valve repair with the MitraClip","volume":"121","author":"K\u00f6rber","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107362_bib0031","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.vph.2015.07.015","article-title":"Platelet reactivity in MitraClip patients","volume":"77","author":"Polzin","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.ahj.2026.107362_bib0032","article-title":"Impact of bleeding complications after transcatheter mitral valve repair","volume":"32","author":"Paukovitsch","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.ahj.2026.107362_bib0025","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.jacc.2005.07.065","article-title":"Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial","volume":"46","author":"Feldman","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107362_bib0033","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2015.11.008","article-title":"Rationale and design of POPular-TAVI: antiPlatelet therapy for patients undergoing transcatheter aortic Valve implantation","volume":"173","author":"Nijenhuis","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107362_bib0034","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR","volume":"385","author":"Van Mieghem","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107362_bib0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107362_bib0020","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00392-022-01988-2","article-title":"Real-world anticoagulatory treatment after percutaneous mitral valve repair using MitraClip: a retrospective, observational study on 1300 patients","volume":"111","author":"Hohmann","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2026.107362_bib0023","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jacc.2013.10.021","article-title":"Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair","volume":"64","author":"Lim","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107362_bib0024","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcin.2014.07.024","volume":"8","author":"Attizzani","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107362_bib0027","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jacc.2017.09.015","article-title":"Outcomes with transcatheter mitral valve repair in the United States: an STS\/ACC TVT registry report","volume":"70","author":"Sorajja","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107362_bib0028","first-page":"728","article-title":"Risk and outcomes of complications during and after MitraClip implantation: experience in 828 patients from the German TRAnscatheter mitral valve interventions (TRAMI) registry","volume":"86","author":"Eggebrecht","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107362_bib0029","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2021.07.058","article-title":"Transcatheter mitral valve therapy in the United States: a report from the STS-ACC TVT registry","volume":"78","author":"Mack","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107362_bib0030","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:09:43Z","timestamp":1779091783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870326000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"alternative-id":["S0002870326000244"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107362","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STrategies for antithrombotic tRreatment following transcatheter edge-to-edge repair in patients with severe mitral regurgitation: Rationale and design of STAR-TEER trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107362"}}